Abstract
New isatin-β-thiocarbohydrazone hybrids 4-17 were designed relied on isatin scaffold to generate various analogs with expected antimicrobial activity. The new hybrids were estimated for antibacterial effectiveness over S. aureus, B. cereus and E. coli, and antifungal efficacy over C. albicans and A. fumigatus. Compound 14 evinced the highest efficacy over A. fumigatus and C. albicans. In addition, 5 and 12 showed eminent efficacy toward A. fumigatus, where compounds 4, 7, 9, 11, 13, 15 and 16 exhibited moderate activity over the same fungus. Moreover, 6 and 9 displayed moderate activity over C. albicans. The new compounds were also estimated for antiquorum-sensing effectiveness against C. violacium, where compound 17 showed interesting activity. In vitro cytotoxicity assay of the new analogs was done over Hela and COS-7 cancer cell lines. All analogs have IC50 values >50 μM toward both cell lines.
Graphical Abstract
Compound 14 demonstrated the highest efficacy over A. fumigatus (MIC = 39.06 µg/mL). Also, it displayed acceptable antiquorum-sensing activity, and it was proven to be an excellent candidate for evolution of new more efficient antifungal analogs.
Acknowledgements
Gratitude to Georgia State University, USA, for implementing spectral analysis.
Supporting Information
Results of in silico studies, detailed experimental procedures, 1H, 13C-NMR and HRMS spectra are presented in the supplemental data.